HCW Biologics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
HCW Biologics Inc. (HCWB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 400 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-31
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 400.00 shares, a 68.00% decline from fiscal 2024.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.25K shares, a 98.63% decline from fiscal 2023.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 91.00K shares, a 61.66% decline from fiscal 2022.
- HCW Biologics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 237.36K shares, a 81.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|
| 2025-12-31 | 400.00 shares 10-K · filed 2026-03-31 | |
| 2024-12-31 | 1.25K shares 10-K · filed 2026-03-31 | 50.00K shares 10-K · filed 2025-03-28 |
| 2023-12-31 | 91.00K shares 10-K · filed 2025-03-28 | |
| 2022-12-31 | 237.36K shares 10-K/A · filed 2024-05-15 | |
| 2021-12-31 | 1.25M shares 10-K · filed 2023-03-28 | |
| 2020-12-31 | 263.98K shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |